|
|
Volumn 138, Issue 3, 2002, Pages 404-
|
|
Treatment considerations while awaiting the ideal bullous pemphigoid trial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFLAMMATORY AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
DAPSONE;
METHYLPREDNISOLONE;
NICOTINAMIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISOLONE;
PREDNISONE;
STEROID;
TETRACYCLINE;
BULLOUS DERMATITIS;
DIFFERENTIAL DIAGNOSIS;
DRUG EFFICACY;
EDITORIAL;
EPIDERMOLYSIS BULLOSA ACQUISITA;
FOLLOW UP;
HUMAN;
IMMUNOGLOBULIN DEPOSITION;
MEDICAL RESEARCH;
METHODOLOGY;
OUTCOMES RESEARCH;
PEER REVIEW;
PEMPHIGOID;
PLASMAPHERESIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SAMPLE SIZE;
TREATMENT OUTCOME;
|
|
EID: 0036124264
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.138.3.404 Document Type: Editorial |
|
Times cited : (5)
|
|
References (1)
|
